![Kaya Panandiker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kaya Panandiker
Corporate Officer/Principal chez
LB PHARMACEUTICALS INC
Profil
Kaya Pai Panandiker is Chief Commercial Officer at LB Pharmaceuticals, Inc. since 2025.
Formerly, Ms. Panandiker was Chief Commercial Officer at Neumora Therapeutics, Inc. Education includes graduate studies at The University of Chicago and undergraduate studies at the University of Wisconsin.
Postes actifs de Kaya Panandiker
| Sociétés | Poste | Début |
|---|---|---|
| LB PHARMACEUTICALS INC | Corporate Officer/Principal | 12/11/2025 |
Anciens postes connus de Kaya Panandiker
| Sociétés | Poste | Fin |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Kaya Panandiker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LB Pharmaceuticals, Inc.
 LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
